X @Bloomberg
Bloomberg·2025-09-29 09:06
UCB shares surged to a record high after analysts said late-stage clinical trial data from rival MoonLake showed UCB’s skin disorder medicine is superior https://t.co/ovOFRtWUJH ...
UCB shares surged to a record high after analysts said late-stage clinical trial data from rival MoonLake showed UCB’s skin disorder medicine is superior https://t.co/ovOFRtWUJH ...